Breakthrough Cancer Treatment IMDELLTRA™ Approved by FDA – Hope for Small Cell Lung Cancer Patients! | Amgen
The FDA has granted approval to Amgen for their groundbreaking new treatment, Imdeltra™ (tarlatamab-dllE), making it the first and only T-cell engager therapy available for extensive-stage small cell lung cancer. This innovative therapy offers hope for patients battling this aggressive form of cancer, providing a much-needed treatment option for those in need. Click to Claim ...
